Main Street Exits NRI Clinical Research and SambaSafety; Buyers Velocity Clinical Research and Stone Point Capital
September 21, 2021
Main Street Capital Corporation fully exited its investments in NRI Clinical Research, LLC (sold to sponsor-backed Velocity Clinical Research) and realized additional gains on the sale of its remaining equity interest in SambaSafety following Stone Point Capital's acquisition. Main Street reported realized gains of approximately $8.8 million on NRI and $4.5 million on SambaSafety as part of these portfolio exits.
- Buyers
- Velocity Clinical Research, Stone Point Capital
- Targets
- NRI Clinical Research, LLC, SambaSafety (Safety Holdings, Inc.)
- Sellers
- Main Street Capital Corporation
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Stone Point Capital Acquires SambaSafety from ABRY Partners
September 1, 2021
Data & Analytics
Stone Point Capital acquired SambaSafety, a provider of cloud-based mobility risk management software, from ABRY Partners; the deal closed on September 1, 2021. SambaSafety, which serves employers, insurers, and background screeners with driver data and analytics and counts over 15,000 customers, will become part of Stone Point's portfolio to expand its exposure to risk, insurance, and data analytics capabilities.
-
Main Street and Iron Creek Partners Complete Leveraged Buyout of Healthcare Data Services Provider
February 5, 2026
Healthcare Services
Main Street Capital Corporation invested $15.3 million to support a leveraged buyout of an unnamed healthcare data services provider, partnering with Iron Creek Partners, LLC (the majority equity investor) and the company's existing owner. Main Street’s capital package included first-lien senior secured term debt and a direct minority equity investment; the target (founded in 1999) cleans and matches provider information for third-party administrators and is headquartered in the Southeastern United States.
-
Main Street Capital Completes $81M Recapitalization of Southeastern Musculoskeletal Care Provider
October 15, 2025
Healthcare Services
Main Street Capital Corporation completed an $81.0 million minority recapitalization of a leading musculoskeletal care management services organization based in the Southeastern United States. The financing, composed of first-lien senior secured term debt and a direct minority equity investment, provides founder liquidity and growth capital to support the company’s multi-site clinical operations across several states.
-
Velocity Clinical Research Acquires VitaLink Research and National Research Institute
September 22, 2021
Healthcare Services
Durham-based Velocity Clinical Research acquired two multi-site clinical research companies—VitaLink Research (six sites in South Carolina) and National Research Institute (five sites in the Los Angeles area)—adding 11 sites to its network. The deal expands Velocity's therapeutic reach and patient recruitment capabilities, creating one of the largest fully integrated site management organizations in the U.S.
-
Main Street Capital Recapitalizes Two Northeastern Commercial Concrete Contractors
January 7, 2026
Construction
Main Street Capital Corporation completed a $35.0 million portfolio investment to facilitate minority recapitalizations of two commercial concrete contracting companies under a single holding company. The financing, which includes first-lien senior secured term debt and a direct minority equity investment, partners with the companies' existing owners and management to provide liquidity and support ongoing operations serving large commercial projects such as warehouses, distribution centers, data centers and cold storage facilities.
-
GHO Capital Acquires Velocity Clinical Research
July 15, 2021
Healthcare Services
Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.